M. SÖNMEZ Et Al. , "Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1, pp.91-92, 2008
SÖNMEZ, M. Et Al. 2008. Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1 , 91-92.
SÖNMEZ, M., OVALI, E., & OMAY, S. B., (2008). Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1, 91-92.
SÖNMEZ, MEHMET, E. OVALI, And S. B. OMAY. "Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1, 91-92, 2008
SÖNMEZ, MEHMET Et Al. "Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1, pp.91-92, 2008
SÖNMEZ, M. OVALI, E. And OMAY, S. B. (2008) . "Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.1, pp.91-92.
@article{article, author={MEHMET SÖNMEZ Et Al. }, title={Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2008, pages={91-92} }